Gambaran Pengobatan Pasien Suspek Covid-19 Rawat Inap RS Brayat Minulya Surakarta  Periode  Maret - Oktober  2020

Widya Adi Putri; Truly Dian Anggraini

doi:10.55181/ijms.v8i2.320

Authors

Widya Adi Putri Sekolah Tinggi Ilmu Kesehatan Nasional, Surakarta
Truly Dian Anggraini Sekolah Tinggi Ilmu Kesehatan Nasional, Surakarta

DOI:

https://doi.org/10.55181/ijms.v8i2.320

Keywords:

Gambaran Pengobatan, Pasien Suspek Covid-19, RS Brayat Minulya

Abstract

Treatment therapy for suspected COVID-19 is an important factor in the recovery of patients with suspected COVID-19. This study aims to determine the characteristics and description of the treatment of patients with suspected COVID-19. This research is a non-experimental research which was conducted retrospectively and analyzed descriptively. The sampling technique was saturated sampling on 55 patients with suspected COVID-19 in inpatient isolation at Brayat Minulya Hospital for the period March-October 2020. The results showed that most of the patients with suspected COVID-19 more dominated by female patients as many as 31 patients (56.36%), in the age group> 65 years as many as 15 patients (27.27%), with the most frequent diagnosis of moderate symptoms as many as 43 patients (78%), with comorbidities dyspepsia. as many as 5 patients (11.90%). Treatment features mostly used the 10.22% Levofloxacin antibiotic group, 6.98% vitamin C group, 1% Oseltamivir antiviral group, 2.74% multivitamin Neurobion, 0.50% zinc supplement, and the symptomatic drug Paracetamol 8.47. %, Omeprasole 6.48%, Ondancentron 4.98%, Ambroxol 4.98%, Methylprednisolone 1.50%, Trifed and Rhinos SR 0.25%, Combivent respule 0.50%, Enoxaparin 1%, Colcichin 0.25 %, Ketorolac 0.25%, comorbid drugs such as Novorapid 1.99%, Amlodipine 1.50%, Isosorbid dinitrate 0.75%, Renxamin 0.50%, Aminoral 0.50%, Haessteril 0.25%, and citicholin 0.25%.

References

Aguila, E. J. T., and Cua, I. H. Y., 2020, Repurposed GI drugs in the treatment of COVID-19, Digestive Diseases and Sciences, 65 (8): 2452-2453

Alkotaji, M., 2020, Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2, International journal of antimicrobial agents, 56 (6): 106-192

Bimantara, D. E., 2020, Peran Vitamin C dalam Pengobatan COVID-19, Jurnal Majority, 9 (1): 123-126

Burhan.E., Susanto.A.D., Nasution.S.A., Ginanjar.E., Pitoyo.C.W., Susilo.A., Firdaus.I., dan Santosa.A., 2020, Protokol Tata Laksana COVID-19, PDPI,PERKI,PAPDI,PERDATIN,IDAI, Jakarta

Chiba, S., 2020, Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19, Wiener klinische Wochenschrift, 1-6

Hidayani, W. R., 2020, Faktor Faktor Risiko Yang Berhubungan Dengan COVID 19: Literature Review, JUKMAS: Jurnal Untuk Masyarakat Sehat, 4 (2): 120-134

Kemenkes RI., 2020, Data COVID-19 Indonesia, https://data.kemkes.go.id/covid19/index.html. diakses tanggal 14 September 2020

Kurniaty, L., Simatupang, A., DS, M., & Lumbantobing, R., 2020, Evaluasi Faktor Resiko dan Hasil Akhir Terapi COVID-19, Studi Kohort Restrospektif Multicenter, skripsi, Program Studi Fakultas Kedokteran, Universitas Kristen Indonesia

Nurwinarsih, F., 2010., Perbandingan efektivitas premedikasi ondansetron dan deksametason dalam mencegah mual dan muntah pasca operasi, skripsi, Program Pasca Sarjana Fakultas Kedokteran Universitas Sebelas Maret, Surakarta

Octaviana, E. S. L., and Anam, K., 2018, Faktor-Faktor Yang Berhubungan Dengan Upaya Keluarga Dalam Pencegahan Penyakit Dispepsia di Wilayah Kerja Puskesmas Mangkatip Kabupaten Barito Selatan, Jurnal Langsat, 5 (1): 11-14

Papadopoulos, V., Li, L., and Samplaski, M., 2020, Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?, Andrology, 2021 (9) : 65-72

Parra-Medina, R., Sarmiento-Monroy, J. C., Rojas-Villarraga, A., Garavito, E., Montealegre Gomez, G., and Gomez-Lopez, A., 2020), Colchicine as a possible therapeutic option in COVID-19 infection, Clinical Rheumatology, 39 (8): 2485-2486

Purnamasari, I.,dan Raharyani, A. E., 2020,Tingkat Pengetahuan Dan Perilaku Masyarakat Kabupaten Wonosobo Tentang Covid-19. Jurnal Ilmiah Kesehatan, 10(1): 33-42

Prakoeswa, F. R. S., 2020, Dasamuka Covid-19: Medica Hospitalia, Journal of Clinical Medicine, 7 (1A): 231-240

Pratama, R., 2020, Studi In Silico Potensi Senyawa Turunan Kortikosteroid Sebagai Obat COVID-19, Jurnal Veteriner Nusantara, 3 (2): 176-186

Pratiwi, R. H., 2017, Mekanisme pertahanan bakteri patogen terhadap antibiotic, Pro-Life, 4 (3): 418-429

Rusdiana, T., dan Akbar, R., 2020, Perkembangan Terkini Terapi Antikoagulan Pada Pasien Covid-19 Bergejala Berat, Jurnal Sains Farmasi dan Klinis, 7(3): 244-250

Setiadi, A. A. P., Wibowo, Y. I., Halim, S. V., Brata, C., Presley, B., dan Setiawan, E., 2020), Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif, Jurnal Farmasi Klinik Indonesia, 9 (1): 70-94

Sieswerda, E., De Boer, M. G., Bonten, M. M., Boersma, W. G., Jonkers, R. E., Aleva, R. M., and Wiersinga, W. J., 2020, Recommendations for antibacterial therapy in adults with COVID-19 an evidence based guideline, Clinical Microbiology and Infection, 27 (1): 61-66

Sugiyono, S.,2010, Metode penelitian kuantitatif dan kualitatif dan R&D,128,Alfabeta, Bandung

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J.,and Zhao, Y., 2020,Clinical characteristics of 138 hospitalized patients with 2019 novel corona virus infected pneumonia in Wuhan, China.Jama,323(11):1061-1069

WHO,2020, Situation reports Corona virus disease 2019, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200418-sitrep-89-covid-19, diakses tanggal 14 September 2020

Yulianti, S. R., Mukaddas, A., dan Faustine, I. , 2014, Profil pengobatan pasien diabetes mellitus tipe 2 di instalasi rawat inap RSUD Undata Palu tahun 2012. Natural Science: Journal of Science and Technology, 3 (1)